indias-first-cas9-protein-based-crispr-covid-19-test-feluda-approved-for-use

India's first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) based COVID-19 test called FELUDA has been approved for use. FELUDA is jointly developed by CSIR-Institute of Genomics & Integrative Biology (IGIB) and TATA Medical and Diagnostics Ltd. FELUDA has 96% sensitivity and 98% specificity for detecting SARSCoV2. CRISPR is a genome-editing technology to diagnosing diseases.As per the developers, the Tata CRISPR test...